Skip to main content
Lawrence Saperstein, MD, Radiology, New Haven, CT, Yale-New Haven Hospital

LawrenceSapersteinMD

Radiology New Haven, CT

Nuclear Medicine, Nuclear Radiology

Physician

Dr. Saperstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Saperstein's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Nuclear Radiology, 2000 - 2001
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Radiology-Diagnostic, 1996 - 2000
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1993 - 1995
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - Present
  • CT State Medical License
    CT State Medical License 2007 - 2025
  • FL State Medical License
    FL State Medical License 2006 - 2017
  • NY State Medical License
    NY State Medical License 1999 - 2013
  • NJ State Medical License
    NJ State Medical License 2001 - 2009
  • American Board of Nuclear Medicine Nuclear Medicine
  • American Board of Radiology Diagnostic Radiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Publications & Presentations

PubMed

Press Mentions

  • Radiologists Bring New Molecular Imaging Technology to Yale
    Radiologists Bring New Molecular Imaging Technology to YaleJanuary 19th, 2021
  • Phase 3 Trial Testing New Imaging Agent for Prostate Cancer Detection Doses First Patient
    Phase 3 Trial Testing New Imaging Agent for Prostate Cancer Detection Doses First PatientDecember 12th, 2018

Hospital Affiliations